37 results on '"Zhang, Sai-Yang"'
Search Results
2. Annual review of PROTAC degraders as anticancer agents in 2022
3. Design, synthesis and biological evaluation of 1,2,3-triazole benzothiazole derivatives as tubulin polymerization inhibitors with potent anti-esophageal cancer activities
4. Discovery of novel coumarin-based derivatives as inhibitors of tubulin polymerization targeting the colchicine binding site with potent anti-gastric cancer activities
5. Design, synthesis and biological evaluation of N-benzylaryl cinnamide derivatives as tubulin polymerization inhibitors capable of promoting YAP degradation with potent anti-gastric cancer activities
6. Design, synthesis and biological evaluation of novel 2,4-diaminopyrimidine cinnamyl derivatives as inhibitors of FAK with potent anti-gastric cancer activities
7. A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy
8. Tubulin degradation: Principles, agents, and applications
9. Discovery of a novel Coumarin-Dihydroquinoxalone derivative MY-673 as a tubulin polymerization inhibitor capable of inhibiting the ERK pathway with potent anti-gastric cancer activities
10. Discovery of novel N-benzylarylamide-dithiocarbamate based derivatives as dual inhibitors of tubulin polymerization and LSD1 that inhibit gastric cancers
11. Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy
12. The dual FAK-HDAC inhibitor MY-1259 displays potent activities in gastric cancers in vitro and in vivo
13. New drug approvals for 2021: Synthesis and clinical applications
14. Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway
15. Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities
16. Discovery of novel 1,2,4-triazine-chalcone hybrids as anti-gastric cancer agents via an axis of ROS-ERK-DR5 in vitro and in vivo
17. Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities
18. Recent progress of oridonin and its derivatives for cancer therapy and drug resistance
19. Discovery of 1,2,4-triazine dithiocarbamate derivatives as NEDDylation agonists to inhibit gastric cancers
20. Discovery of novel coumarin-based derivatives as inhibitors of tubulin polymerization targeting the colchicine binding site with potent anti-gastric cancer activities
21. Engineering Multifunctional Thylakoid as an Oxygen Self-Supplying Photosensitizer for Esophageal Squamous Cell Carcinoma-Targeted Photodynamic Therapy
22. Discovery of novel arylamide derivatives containing piperazine moiety as inhibitors of tubulin polymerisation with potent liver cancer inhibitory activity.
23. Discovery of novel tranylcypromine-based derivatives as LSD1 inhibitors for gastric cancer treatment
24. A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle
25. Design, synthesis and anti-tumor activity studies of novel pyrido[3, 4-d]pyrimidine derivatives
26. Design, Synthesis and Biological Evaluation of [1,2,4]Triazolo[1,5-a]pyrimidine Indole Derivatives against Gastric Cancer Cells MGC-803 via the Suppression of ERK Signaling Pathway
27. A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo
28. Discovery of Novel Coumarin-Indole Derivatives As Tubulin Polymerization Inhibitors with Potent Anti-Gastric Cancer Activities
29. A Novel Aromatic Amide Derivative SY-65 co-Targeting Tubulin and Histone Deacetylase 1 with Potent Anticancer Activity in Vitro and in Vivo
30. WITHDRAWN: Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization
31. Design, Synthesis, and Anticancer Activity Studies of Novel Quinoline-Chalcone Derivatives
32. Design, Synthesis and Biological Evaluation of [1,2,4]Triazolo[1,5- a ]pyrimidine Indole Derivatives against Gastric Cancer Cells MGC-803 via the Suppression of ERK Signaling Pathway.
33. Discovery of N-aryl sulphonamide-quinazoline derivatives as anti-gastric cancer agents in vitro and in vivo via activating the Hippo signalling pathway.
34. Progress in the development of small molecular inhibitors of the Bruton's tyrosine kinase (BTK) as a promising cancer therapy.
35. Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization.
36. Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics.
37. Targeting focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degraders.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.